Mohammed S Alharthi
Overview
Explore the profile of Mohammed S Alharthi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
0
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alharthi M, Alsulami F, Fathelrahman A, Alqarni M, Alorfi N, Alzahrani M
Healthcare (Basel)
. 2025 Mar;
13(5).
PMID: 40077034
Over the counter (OTC) medications are readily accessible to the public and can be obtained without a prescription for self-care. Ensuring their safe and effective use is essential to safeguarding...
2.
Alharthi M, Alshehri A, Baali F, Altuwairqi N, Altalhi M, Almalki R, et al.
Front Public Health
. 2025 Mar;
13:1534176.
PMID: 40046134
Background: Seasonal influenza vaccination is essential for reducing the risk and impact of influenza. Makkah region in Saudi Arabia, a destination for millions of pilgrims during Hajj and Umrah, presents...
3.
Alharthi M
Medicine (Baltimore)
. 2025 Feb;
103(52):e41073.
PMID: 39969346
Huntington disease (HD) is a hereditary neurodegenerative condition characterized by progression of motor, cognitive, and psychiatric abnormalities. Despite the lack of definitive medications, current research efforts are actively assessing novel...
4.
Alharthi M, Almalki H, Alsubaie F, Alotaibe F, Abuasiah A, Basha F, et al.
Front Med (Lausanne)
. 2024 Nov;
11:1435707.
PMID: 39600929
Introduction: Over-the-counter (OTC) medications are those obtained without a medical prescription from a healthcare professional. With the increasing availability of information from various sources, including social media, pharmacy students may...
5.
Alharthi M
Front Med (Lausanne)
. 2024 Nov;
11:1487852.
PMID: 39582972
Background: Transition to electronic prescribing (e-prescribing) systems, such as Wasfaty, represents a significant advancement in healthcare. Introduced by the Saudi Arabian Ministry of Health in 2019, Wasfaty aims to enhance...
6.
Basurrah A, Atteiah A, Ajlan B, Subhan I, Alharthi M, Rezk E
J Neurosurg Case Lessons
. 2024 Aug;
8(8).
PMID: 39159491
Background: Vision loss following supine craniotomy is an unexpected and devastating complication for the patient and the operating team. Postoperative vision loss (POVL) is commonly associated with cardiac, spinal, neck,...
7.
Alharthi M, Scott S, Hughes C, Bond C, Hatah E, Bryant L, et al.
Int J Pharm Pract
. 2024 Feb;
32(2):180-185.
PMID: 38387608
Background: Medication review (MR) is the systematic assessment of a patient's medications for safety and effectiveness by a healthcare professional. The language used to describe MR activity, such as stopped...
8.
Alshehri A, Alrehaili H, Batayyib S, Saeed A, Alharthi M, Alasmari R
Cureus
. 2023 Apr;
15(3):e36454.
PMID: 37090325
Pelvic fractures with sacroiliac extension are significant and complicated orthopedic injuries that pose a challenge in management and favorable outcomes. A 50-year-old obese female presented after a motor vehicle accident...
9.
Arishi N, Althomali N, Dighriri I, Alharthi M, Alqurashi G, Musharraf R, et al.
Cureus
. 2023 Feb;
15(1):e34158.
PMID: 36843775
Fluvoxamine (FLV) is a well-tolerated, widely accessible antidepressant of the selective serotonin reuptake inhibitor (SSRI) category. It was formerly used to reduce anxiety, obsessive-compulsive disorder, panic attacks, and depression. Severe...